![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: USP42 |
Gene summary for USP42 |
![]() |
Gene information | Species | Human | Gene symbol | USP42 | Gene ID | 84132 |
Gene name | ubiquitin specific peptidase 42 | |
Gene Alias | USP42 | |
Cytomap | 7p22.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q9H9J4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84132 | USP42 | LZE4T | Human | Esophagus | ESCC | 3.61e-14 | 2.18e-01 | 0.0811 |
84132 | USP42 | LZE7T | Human | Esophagus | ESCC | 3.87e-04 | 2.22e-01 | 0.0667 |
84132 | USP42 | LZE20T | Human | Esophagus | ESCC | 5.19e-06 | 1.24e-01 | 0.0662 |
84132 | USP42 | LZE24T | Human | Esophagus | ESCC | 2.48e-11 | 3.76e-01 | 0.0596 |
84132 | USP42 | P1T-E | Human | Esophagus | ESCC | 3.76e-07 | 2.86e-01 | 0.0875 |
84132 | USP42 | P2T-E | Human | Esophagus | ESCC | 9.48e-23 | 4.77e-01 | 0.1177 |
84132 | USP42 | P4T-E | Human | Esophagus | ESCC | 2.35e-19 | 2.17e-01 | 0.1323 |
84132 | USP42 | P5T-E | Human | Esophagus | ESCC | 3.08e-14 | 1.53e-01 | 0.1327 |
84132 | USP42 | P8T-E | Human | Esophagus | ESCC | 7.98e-11 | 2.33e-01 | 0.0889 |
84132 | USP42 | P9T-E | Human | Esophagus | ESCC | 1.73e-15 | 3.05e-01 | 0.1131 |
84132 | USP42 | P10T-E | Human | Esophagus | ESCC | 7.33e-20 | 3.03e-01 | 0.116 |
84132 | USP42 | P11T-E | Human | Esophagus | ESCC | 4.31e-15 | 4.76e-01 | 0.1426 |
84132 | USP42 | P12T-E | Human | Esophagus | ESCC | 1.21e-18 | 4.08e-01 | 0.1122 |
84132 | USP42 | P15T-E | Human | Esophagus | ESCC | 1.11e-23 | 5.54e-01 | 0.1149 |
84132 | USP42 | P16T-E | Human | Esophagus | ESCC | 3.31e-29 | 4.10e-01 | 0.1153 |
84132 | USP42 | P17T-E | Human | Esophagus | ESCC | 1.48e-05 | 2.52e-01 | 0.1278 |
84132 | USP42 | P20T-E | Human | Esophagus | ESCC | 1.72e-10 | 3.23e-01 | 0.1124 |
84132 | USP42 | P21T-E | Human | Esophagus | ESCC | 3.49e-12 | 1.73e-01 | 0.1617 |
84132 | USP42 | P22T-E | Human | Esophagus | ESCC | 5.45e-16 | 1.79e-01 | 0.1236 |
84132 | USP42 | P23T-E | Human | Esophagus | ESCC | 1.22e-10 | 3.00e-01 | 0.108 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:007064612 | Esophagus | ESCC | protein modification by small protein removal | 95/8552 | 157/18723 | 1.25e-04 | 8.56e-04 | 95 |
GO:00165793 | Esophagus | ESCC | protein deubiquitination | 79/8552 | 139/18723 | 5.23e-03 | 1.97e-02 | 79 |
GO:00706461 | Liver | HCC | protein modification by small protein removal | 91/7958 | 157/18723 | 6.50e-05 | 5.92e-04 | 91 |
GO:00165791 | Liver | HCC | protein deubiquitination | 78/7958 | 139/18723 | 8.13e-04 | 4.87e-03 | 78 |
GO:00706462 | Oral cavity | OSCC | protein modification by small protein removal | 77/7305 | 157/18723 | 6.55e-03 | 2.43e-02 | 77 |
GO:007064611 | Oral cavity | EOLP | protein modification by small protein removal | 33/2218 | 157/18723 | 7.04e-04 | 5.78e-03 | 33 |
GO:00165792 | Oral cavity | EOLP | protein deubiquitination | 28/2218 | 139/18723 | 3.29e-03 | 1.90e-02 | 28 |
GO:00706465 | Thyroid | PTC | protein modification by small protein removal | 71/5968 | 157/18723 | 3.03e-04 | 2.12e-03 | 71 |
GO:00165794 | Thyroid | PTC | protein deubiquitination | 59/5968 | 139/18723 | 5.50e-03 | 2.50e-02 | 59 |
GO:007064613 | Thyroid | ATC | protein modification by small protein removal | 71/6293 | 157/18723 | 1.59e-03 | 7.99e-03 | 71 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
USP42 | SNV | Missense_Mutation | novel | c.650N>A | p.Ser217Asn | p.S217N | Q9H9J4 | protein_coding | deleterious(0) | possibly_damaging(0.537) | TCGA-BR-4292-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
USP42 | SNV | Missense_Mutation | rs754564754 | c.1472N>G | p.Asn491Ser | p.N491S | Q9H9J4 | protein_coding | tolerated(0.56) | benign(0.015) | TCGA-BR-4361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
USP42 | SNV | Missense_Mutation | rs758322239 | c.1343N>T | p.Ala448Val | p.A448V | Q9H9J4 | protein_coding | tolerated(0.09) | benign(0.068) | TCGA-BR-8284-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
USP42 | SNV | Missense_Mutation | c.2566N>G | p.Ser856Gly | p.S856G | Q9H9J4 | protein_coding | tolerated(0.37) | benign(0.23) | TCGA-BR-8589-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
USP42 | SNV | Missense_Mutation | c.1621N>A | p.Leu541Ile | p.L541I | Q9H9J4 | protein_coding | tolerated(0.1) | benign(0.015) | TCGA-BR-A453-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
USP42 | SNV | Missense_Mutation | rs748410824 | c.2528N>T | p.Pro843Leu | p.P843L | Q9H9J4 | protein_coding | tolerated(0.67) | benign(0.01) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
USP42 | SNV | Missense_Mutation | rs371531352 | c.3875G>A | p.Arg1292His | p.R1292H | Q9H9J4 | protein_coding | tolerated(0.28) | benign(0.011) | TCGA-D7-A6EY-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
USP42 | SNV | Missense_Mutation | c.1346N>T | p.Pro449Leu | p.P449L | Q9H9J4 | protein_coding | tolerated(0.06) | benign(0.295) | TCGA-HF-7132-01 | Stomach | stomach adenocarcinoma | Male | Unknown | I/II | Chemotherapy | fluorouracil | SD | |
USP42 | SNV | Missense_Mutation | rs772525190 | c.1657N>A | p.Val553Ile | p.V553I | Q9H9J4 | protein_coding | tolerated(0.24) | benign(0.019) | TCGA-HU-8602-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Chemotherapy | xeloda | CR |
USP42 | SNV | Missense_Mutation | c.154N>T | p.Leu52Phe | p.L52F | Q9H9J4 | protein_coding | deleterious(0.01) | possibly_damaging(0.867) | TCGA-HU-8608-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | doxifluridine | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |